Found: 12
Select item for more details and to access through your institution.
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 318, doi. 10.1016/j.clcc.2021.07.003
- By:
- Publication type:
- Article
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-1117-2
- By:
- Publication type:
- Article
The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 704, doi. 10.1111/liv.14314
- By:
- Publication type:
- Article
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability‐High End‐Stage Cancers and Poor Performance Status Related to High Disease Burden.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 803, doi. 10.1634/theoncologist.2020-0014
- By:
- Publication type:
- Article
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 481, doi. 10.1634/theoncologist.2019-0611
- By:
- Publication type:
- Article
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.712053
- By:
- Publication type:
- Article
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5513, doi. 10.3390/cancers14225513
- By:
- Publication type:
- Article
Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 369, doi. 10.3390/cancers11030369
- By:
- Publication type:
- Article
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 3, p. 2455, doi. 10.1007/s00520-021-06652-5
- By:
- Publication type:
- Article
Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).
- Published in:
- Oncology Reports, 2023, v. 49, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Successful treatment of gemcitabineinduced acute interstitial pneumonia with imatinib mesylate: a case report.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2833-9
- By:
- Publication type:
- Article